Novartis (Procto-Glyvenol)

Novartis (Procto-Glyvenol) Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.
Financing Rounds 1

Novartis (Procto-Glyvenol) General Information

Description

The Procto-Glyvenol medicine of Novartis. The asset is utilized for the localized treatment of internal and external hemorrhoids.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Novartis Campus
  • Forum 1
  • 4056 Basel
  • Switzerland
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Procto-Glyvenol) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Procto-Glyvenol)‘s full profile, request access.

Request a free trial

Novartis (Procto-Glyvenol) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Procto-Glyvenol)‘s full profile, request access.

Request a free trial